Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab

Bone marrow transplantation (BMT) was introduced as a treatment option 15 years ago for severe, drug-resistant multiple sclerosis (MS). Up until now, BMT has been undertaken in relatively few patients worldwide, with moderate success, and recent studies suggest that patients with early, highly aggre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mouzaki, Athanasia, Koutsokera, Maria, Dervilli, Zoe, Rodi, Maria, Kalavrizioti, Dimitra, Dimisianos, Nikolaos, Matsoukas, Ioannis, Papathanasopoulos, Panagiotis
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2010
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2962327/
https://ncbi.nlm.nih.gov/pubmed/21042570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S13648
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge